Manisha Shah, MD
Enriched profileAssociate Professor of Internal Medicine · The Ohio State University Medical Center
Manisha Shah is Associate Professor of Internal Medicine at The Ohio State University Medical Center. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 12 Nov 2026
Overview
Updated 17 Nov 2026
Manisha Shah, M.D., is Associate Professor of Internal Medicine at The Ohio State University Medical Center. It also documents an investigator role on 10 registered clinical trials, 3 NIH-funded awards (2002–2020).
- Top research focus: Carcinoid Tumor
- 10 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 12 Nov 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Sponsor: National Cancer Institute (NCI)
- Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
69.2%Antidiarrheal38.5%Diphenoxylate-Atropine100%Part D<11 patientsCorticosteroid30.8%Prednisone100%Part D<11 patientsCancer & immunology
30.8%Kinase inhibitor30.8%Lenvima100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 12 Nov 2026
3 NIH research awards on record, funded 2002–2020 per NIH RePORTER. The latest:
- Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
Beckman Research Institute/city of Hope
FY2020$226,665R01CA246553 - Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
Ohio State University
FY2020$193,780R01CA246553 - CONGESTIVE HEART FAILURE AND SKELETAL METABOLISM
Ut Southwestern Medical Center
FY2009$17,838P41RR002584
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 12 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
convenehealthcare.com/specialists/profile/dr-manisha-shah-columbus
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →convenehealthcare.com ↗ - Other
medifind.com/doctors/manisha-shah/7526675
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 12 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nytimes.com ↗
- CBS Detroit feature on Aretha Franklin's cancer doctors
naming Manisha Shah of Ohio State University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cbsnews.com ↗ - SWOG news on immunotherapy combination for neuroendocrine tumors quoting Manisha Shah
MD, of The Ohio State University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →swog.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH